Infliximab for the treatment of 4 cases of toxic epidermal necrolysis

Institutions

Publication Details

Journal
Chinese Journal of Dermatology
Published
2024-08-19
DOI
https://doi.org/10.35541/cjd.20220887
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Infliximab for the treatment of 4 cases of toxic epidermal necrolysis

Chinese Journal of Dermatology
Drug-Induced Adverse Reactions
article

Infliximab for the treatment of 4 cases of toxic epidermal necrolysis

article en

Abstract

No abstract available for this paper.
Chinese Journal of Dermatology
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN)
Good health and well-being
Openalex Percentile: Top 87%
Drug-Induced Adverse Reactions
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Infliximab for the treatment of 4 cases of toxic epidermal necrolysis · Chinese Journal of Dermatology (2024) | TGRS Research Map | TGRS